Consumers' Confidence in Prescription Drugs and FDA's Approval Process Revealed

Strategic Insights -

A recent poll conducted by Associated Press and Ipsos Public Affairs sheds light on the changing dynamics between pharmaceutical manufacturers and informed health consumers. The survey found that despite concerns over COX-2 inhibitors, Americans remain confident in the safety of prescription drugs. However, they also expect the FDA to do a better job of scrutinizing drugs before they come to market and communicating the risks associated with them. Pharmaceutical manufacturers, including Pfizer's Celebrex and Bextra, Merck & Co's Vioxx, will need to address public safety concerns and information demands to maintain consumer confidence.

Key Takeaways:

  • The survey suggests that Americans are more confident in the safety of prescription drugs than in the FDA's ability to ensure safety, with 53% of respondents expressing confidence in prescription drugs, compared to 31% in the FDA.
  • Despite concerns over COX-2 inhibitors, the survey found that 61% of Americans believe that prescription drugs are safe, while 64% believe that the risks associated with these drugs are "often" or "usually" communicated to the public.
  • The survey highlights the need for pharmaceutical manufacturers to effectively communicate the risks and benefits of their products, with 71% of Americans agreeing that the FDA should do a better job of scrutinizing drugs before they come to market.
  • Fariba Zamaniyan, vice president of marketing and business development at Ipsos Health, warns that pharmaceutical manufacturers risk losing consumer confidence if they fail to address public safety concerns and information demands.
  • The poll suggests that with greater consumer brand awareness comes increased sensitivity to shifts in public opinion, consumer confidence, and corporate credibility, with 74% of Americans agreeing that this is the case.

Statistics:

  • 53% of Americans express confidence in the safety of prescription drugs.
  • 31% of Americans express confidence in the FDA's ability to ensure drug safety.
  • 61% of Americans believe that prescription drugs are safe.
  • 64% of Americans believe that the risks associated with prescription drugs are "often" or "usually" communicated to the public.
  • 71% of Americans agree that the FDA should do a better job of scrutinizing drugs before they come to market.
  • 74% of Americans believe that greater consumer brand awareness leads to increased sensitivity to shifts in public opinion, consumer confidence, and corporate credibility.

Sources:

  • Associated Press (no date)
  • Ipsos Public Affairs (no date)
  • Zamaniyan, F. (no date)
  • "Pharmaceutical Manufacturers Must Address Consumer Concerns to Maintain Confidence, Poll Finds." Associated Press (Associated Press and Ipsos Public Affairs) (no date)
  • Ipsos Public Affairs (no date)
  • Zamaniyan, F. (no date)